Publication | Open Access
Binimetinib versus dacarbazine in patients with advanced NRAS-mutant melanoma (NEMO): a multicentre, open-label, randomised, phase 3 trial
482
Citations
33
References
2017
Year
OncologyBinimetinib Versus DacarbazineMedicineMelanomaPharmacotherapyCancer TreatmentPharmacologyRadiation OncologyAdvanced Nras-mutant MelanomaMolecular Oncology
| Year | Citations | |
|---|---|---|
Page 1
Page 1